Efavirenz as a potential drug for the treatment of triple-negative breast cancers

被引：0
|
作者：
P.-T. Chiou
S. Ohms
P. G. Board
J. E. Dahlstrom
D. Rangasamy
M. G. Casarotto
机构：
[1] The Australian National University,ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research
[2] The Australian National University,The John Curtin School of Medical Research
[3] The Australian National University,Anatomical Pathology, ACT Pathology, Canberra Hospital and ANU Medical School, ANU College of Health and Medicine
来源：
Clinical and Translational Oncology | 2021年 / 23卷
关键词：
Triple-negative breast cancer; Efavirenz; LINE-1; Retrotransposon; Fatty acid metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 363
页数：10
相关论文
共 50 条
  • [31] Triple-Negative Breast Cancers: Different Sensitivity to Chemotheray
    Choi, Y. L.
    Oh, E.
    Kim, Y.
    Park, Y. H.
    Cho, E. Y.
    Lee, J. E.
    Kim, J. H.
    Nam, S. J.
    Lim, Y. H.
    Yang, J. H.
    Shin, Y. K.
    Hong, Y. C.
    LABORATORY INVESTIGATION, 2010, 90 : 41A - 41A
  • [32] Update on triple-negative breast cancers - highlighting subtyping update and treatment implication
    Tsang, Julia Y.
    Tse, Gary M.
    HISTOPATHOLOGY, 2023, 82 (01) : 17 - 35
  • [33] Neoadjuvant treatment for HER-2-positive and triple-negative breast cancers
    Sousa, B.
    Cardoso, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 237 - 242
  • [34] Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
    Jiang, Yi-Zhou
    Ma, Ding
    Suo, Chen
    Shi, Jinxiu
    Xue, Mengzhu
    Hu, Xin
    Xiao, Yi
    Yu, Ke-Da
    Liu, Yi-Rong
    Yu, Ying
    Zheng, Yuanting
    Li, Xiangnan
    Zhang, Chenhui
    Hu, Pengchen
    Zhang, Jing
    Hua, Qi
    Zhang, Jiyang
    Hou, Wanwan
    Ren, Luyao
    Bao, Ding
    Li, Bingying
    Yang, Jingcheng
    Yao, Ling
    Zuo, Wen-Jia
    Zhao, Shen
    Gong, Yue
    Ren, Yi-Xing
    Zhao, Ya-Xin
    Yang, Yun-Song
    Niu, Zhenmin
    Cao, Zhi-Gang
    Stover, Daniel G.
    Verschraegen, Claire
    Kaklamani, Virginia
    Daemen, Anneleen
    Benson, John R.
    Takabe, Kazuaki
    Bai, Fan
    Li, Da-Qiang
    Wang, Peng
    Shi, Leming
    Huang, Wei
    Shao, Zhi-Ming
    CANCER CELL, 2019, 35 (03) : 428 - +
  • [35] A Biomimetic Drug Delivery System Targeting Tumor Hypoxia in Triple-Negative Breast Cancers
    Tatiparti, Katyayani
    Rauf, Mohd Ahmar
    Sau, Samaresh
    Iyer, Arun K.
    APPLIED SCIENCES-BASEL, 2020, 10 (03):
  • [36] Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
    Masci, Domiziana
    Naro, Chiara
    Puxeddu, Michela
    Urbani, Andrea
    Sette, Claudio
    La Regina, Giuseppe
    Silvestri, Romano
    MOLECULES, 2023, 28 (22):
  • [37] Drug Repurposing for Triple-Negative Breast Cancer
    Avalos-Moreno, Marta
    Lopez-Tejada, Araceli
    Blaya-Canovas, Jose L.
    Cara-Lupianez, Francisca E.
    Gonzalez-Gonzalez, Adrian
    Lorente, Jose A.
    Sanchez-Rovira, Pedro
    Granados-Principal, Sergio
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 34
  • [38] Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
    Soung, Young Hwa
    Chung, Heesung
    Yan, Cecilia
    Fesler, Andrew
    Kim, Hyungjin
    Oh, Eok-Soo
    Ju, Jingfang
    Chung, Jun
    CANCERS, 2020, 12 (08) : 1 - 16
  • [39] Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
    Anselmino, L. E.
    Baglioni, M. V.
    Reynoso, G.
    Rozados, V. R.
    Scharovsky, O. G.
    Rico, M. J.
    Menacho-Marquez, M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
    L. E. Anselmino
    M. V. Baglioni
    G. Reynoso
    V. R. Rozados
    O. G. Scharovsky
    M. J. Rico
    M. Menacho-Márquez
    Scientific Reports, 13
12345